)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Penumbra
Penumbra (PEN) investor relations material
Penumbra Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
Q3 revenue rose 15.6% YoY to $410.1M; operating income increased to $50.7M, while net income declined to $42.3M.
Nine-month revenue rose 15.4% YoY to $1.175B; operating income was $130.0M, while net income declined to $109.7M from $130.3M.
Financial highlights
Q3 gross profit was $280.3M versus $240.4M; operating expenses were $229.6M, including R&D of $25.4M and SG&A of $204.2M.
Q3 net income was $42.3M versus $45.9M; diluted EPS was $1.07 versus $1.17.
Nine-month gross profit was $798.7M versus $680.3M; diluted EPS was $2.77 versus $3.32.
Nine-month operating cash flow increased to $174.6M from $152.2M.
Outlook and guidance
No FY 2026 financial guidance or Q3 results conference call was provided given the pending Boston Scientific acquisition.
Liquidity is expected to cover requirements for at least 12 months; priorities include operations, manufacturing expansion, inventory, R&D and capital expenditures.
Continued investment planned for product launches, manufacturing and IT infrastructure, and international expansion; additional financing may be considered.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Penumbra
- Q2 2026 revenue up 14.9% to $390M, net income $34.8M, $14.5B Boston Scientific merger announced.PEN
Q2 2026 - Q1 2026 revenue rose 15.6% to $374.8M; net income was $32.6M; merger pending.PENQ1 2026
- Key votes on directors, auditor, and executive pay set for June 2026 annual meeting.PENProxy filing
- Annual meeting covers director elections, auditor ratification, and say-on-pay, with merger pending.PENProxy filing
- Shareholders to vote on Penumbra's $374/share cash or stock merger with Boston Scientific.PENProxy filing
- Double-digit revenue and profit growth in 2025, with strong U.S. product sales and improved margins.PENQ4 2025
- Mechanical thrombectomy proved superior to anticoagulation for intermediate high-risk PE, reshaping care.PENTranscatheter Cardiovascular Therapeutics (TCT) Conference 2025
- Q3 revenue up 11.1% to $301M, with 21.2% U.S. thrombectomy growth and margin expansion.PENQ3 2024
- Q2 revenue up 14.5% with strong thrombectomy growth, but guidance cut on global headwinds.PENQ2 2024
Next Penumbra earnings date
Q4 202619 Feb, 2027
Penumbra
Next Penumbra earnings date
Q4 202619 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Penumbra Inc designs, develops, and markets medical devices for neurovascular and vascular conditions. Its products support treatments for stroke, peripheral embolization, and thrombectomy procedures, serving healthcare providers and hospitals worldwide. Penumbra operates within the healthcare and medical device sectors. The company is headquartered in Alameda, California, and its shares are listed on the NYSE.